Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FP3QN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,184
Award facts
- Contract value 100% obligated
- $10,183.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $10,183.76 delivery order to Amerisourcebergen Drug Corp on July 10, 2026, for RINVOQ ER 15 MG tablets (30-count units), with an ultimate completion date of July 13, 2026.
Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis with no set-aside. Amerisourcebergen Drug Corp is a pharmaceutical distributor and medical supplier subsidiary of Cencora, Inc., competing without small business designations on full-and-open competitive awards.
Quick answers
Who was awarded contract SPE2DR26FP3QN?
SPE2DR26FP3QN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 10, 2026.
How much is contract SPE2DR26FP3QN worth?
The government has obligated $10,184 on SPE2DR26FP3QN.
Is contract SPE2DR26FP3QN an order under another contract?
Yes. SPE2DR26FP3QN is a delivery order under SPE2DR25D3014, an indefinite delivery contract.
Was contract SPE2DR26FP3QN competed?
The extent of competition for SPE2DR26FP3QN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award